Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_assertion type Assertion NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_head.
- NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_assertion description "[Inhibitors of the PI3K pathway are in clinical testing in patients with solid tumors, including uterine cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_provenance.
- NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_assertion evidence source_evidence_literature NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_provenance.
- NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_assertion SIO_000772 21903247 NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_provenance.
- NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_assertion wasDerivedFrom befree-2016 NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_provenance.
- NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_assertion wasGeneratedBy ECO_0000203 NP922347.RATn-Mu-dSPJ0_ft9BvY0j30I2VNbKQmyjVerJBD5_B7c130_provenance.